Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (1006)	12/16/1997 8:48:00 AM
From: Dauntless	Read Replies (2) \| Respond to of 7041

Bill - welcome to the thread. Since you're apparently not shy about your opinions, I wonder if you would share the information that has led you to believe that Zonagen's ED drug (Vasomax) is ineffective? This is, after all, the key argument supporting your position - so please let us have your insight. As a CPA, I'm sure that you're aware of how long it took & how much money was sunk in Amgen, Genetek, etc. I was unaware that $ invested & time in development were indicators of a scam - especially in this industry. But then again, most of us are not CPA's - otherwise we would have noticed Zonagen's "deteriorating fundamentals". When did they begin to deteriorate? When they recently raised >$70 million; when they completed Phase III clinicals; when they signed the deal with Schering; all very ominous events!! Zonagen will begin generating significant revenues when Vasomax is approved - not before - we all know this & accept it. The vote of confidence from Schering, directed by professional pharmaceutical management, means a little more than the opinion of CPA's, Brokers, analysts, etc. BTW - Zona's burn rate, excluding clinicals - which are essentially over for Vasomax, is about $5.5 million per year. And if that goes up, it means they're developing another product - so there goes that argument. IMHO, it is you and the other shorts (amateur, like yourself - or "professional" like Asholio) that are guilty of hype. You have been fortunate with the Asian & tech sector paranoia - but it will end - I hope you don't get hurt too badly. Zonagen has been doing exactly what it should be doing - & doing it well. But please - begin to build your credibility by sharing your technical information on the ineffectiveness of Vasomax - so we all can save ourselves. Good luck.